Professor Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She joined UK Biobank as Senior Epidemiologist in 2011, and became Chief Scientist in 2019, where she is responsible for following-up participants both through linkage with routine health-related datasets, and through web-based questionnaires. She is also involved in developing the scientific strategy for future enhancements for the study. Her research interest is largely in the role of diet, obesity and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world.
Human cytomegalovirus and risk of incident cardiovascular disease in UK Biobank
Hamilton E. et al, (2021), The Journal of Infectious Diseases
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8.
Caleyachetty R. et al, (2021), J Am Coll Cardiol, 78, 56 - 65
Physical activity in relation to circulating hormone concentrations in 117,100 men in UK Biobank.
Watts EL. et al, (2021), Cancer Causes Control
Prospective analysis of circulating metabolites and endometrial cancer risk.
Dossus L. et al, (2021), Gynecol Oncol
Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N. et al, (2020), EBioMedicine, 62